Palvella Therapeutics, Inc. (PVLA) Capital expenditures 2016–2023
Palvella Therapeutics, Inc. (PVLA) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$171,000FY2023 · since FY2016: $560,000 → $171,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $171,000 | -83.6% |
| FY2022 | $1.0M | +9.7% |
| FY2021 | $949,000 | -65.2% |
| FY2020 | $2.7M | +10.7% |
| FY2019 | $2.5M | +45.0% |
| FY2018 | $1.7M | -12.9% |
| FY2017 | $1.9M | +248.2% |
| FY2016 | $560,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice